Natixis’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-47,250
| Closed | -$670K | – | 1058 |
|
|
2023
Q4 | $670K | Buy |
47,250
+7,600
| +19% | +$108K | ﹤0.01% | 565 |
|
|
2023
Q3 | $482K | Buy |
39,650
+39,600
| +79,200% | +$482K | ﹤0.01% | 598 |
|
|
2023
Q2 | $628 | Buy |
+50
| New | +$628 | ﹤0.01% | 962 |
|
|
2021
Q2 | – | Sell |
-18,186
| Closed | -$180K | – | 893 |
|
|
2021
Q1 | $180K | Sell |
18,186
-97,484
| -84% | -$965K | ﹤0.01% | 1031 |
|
|
2020
Q4 | $2.67M | Buy |
+115,670
| New | +$2.67M | 0.01% | 627 |
|
|
2019
Q1 | – | Sell |
-37,872
| Closed | -$363K | – | 818 |
|
|
2018
Q4 | $363K | Buy |
37,872
+2,472
| +7% | +$23.7K | ﹤0.01% | 606 |
|
|
2018
Q3 | $428K | Sell |
35,400
-41
| -0.1% | -$496 | ﹤0.01% | 649 |
|
|
2018
Q2 | $554K | Buy |
35,441
+15,839
| +81% | +$248K | ﹤0.01% | 683 |
|
|
2018
Q1 | $295K | Sell |
19,602
-17,309
| -47% | -$260K | ﹤0.01% | 750 |
|
|
2017
Q4 | $531K | Buy |
+36,911
| New | +$531K | ﹤0.01% | 593 |
|